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In situ derivatization to methyl esters (FAME) and fractionation of EFA and NEFA.
A B S T R A C T
Despite their important role in tissues, fluids and foods, the analysis of non-esterified fatty acids (NEFA) as methyl
esters (NEFAME) is performed using expensive, cumbersome and time-consuming procedures that needs of
isolation, fractionation and derivatization steps. However, Yi et al. [1] proposed a promising in situ, single-step
procedure to analyze esterified fatty acids (EFA) and NEFA from a same sample on the basis that acylglycerols and
free fatty acids can be derivatized using specific reactions. However, according to the data presented in this
research work, some modifications need to be performed to increase the reliability of the method:
 Increment of the transesterification performance by adding hexane to the reaction mixture, decreasing the
time for the derivatization of acylglycerols from 10min to 3–4min and stopping the reaction with sulfuric
acid.* Corresponding author.
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 Avoid cross-contamination of the NEFAME extract by adding 500mL of water after collection of EFA methyl
esters (EFAME).
 Samples are spiked with three internal standards: a triacylglycerol (to calculate the concentration of EFA), a
free fatty acid (to calculate NEFA) and a FAME (to control isolation of FAME and cross-contamination).
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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All the modifications described in this work were carried out in order to increase the
transesterification and esterification performance of fatty acids as well as to prevent cross
contamination of the NEFAME extract with FAME from EFA when assaying the method described
by Yi et al. [1].
Chemicals
Hexane, dimethylformamide (DMF), methyl tert-butyl ether (MTBE) and methanol (MeOH) were
HPLC grade and sulphuric acid was analytical grade (VWR Scientific, Carnaxide, Portugal). Supelco
37 FAME mix, methyl tricosanoate (99%; FAME-C23), methyl undecanoate (99%; FAME-C11),
nonadecanoic acid (99%; FFA-C19), tung oil, sodium methoxide (MetNa; 95%) and potassium
hydroxide (KOH) were obtained from Sigma (Sigma-Aldrich, St. Louis, MO, USA); GLC-Nestlé36 FAME
mix, tritridecanoin (99%) and heptadecanoic acid (99%) were from Nu-Chek Prep, Inc. (Elysian, MN,
USA). Undecanoic acid (99%; FAME-C11; ALFA AESAR, Karlsruhe, Germany) was obtained from VWR
(Carnaxide, Portugal) while butterfat CRM-164 (EU Commission; Brussels, Belgium) was from Fedelco,
Inc. (Madrid, Spain). Seronorm Lipid (Sero, Billingstad, Norway) was purchased to Bioportugal (Porto,
Portugal). Earthoil (Bury St. Edmunds, Suffolk, UK) kindly donated the pomegranate oil (PMO). All the
experiments were performed using 14mL borosilicate glass tubes (16mm125mm) with acid/heat
resistant cap (VWR international, Carnaxide, Portugal).
Instrumentation
In Tests 1–3, EFAME[2_TD$DIFF] and NEFAME were analyzed in a gas chromatrograph HP6890A (Hewlett-
Packard, Avondale, PA, USA), equipped with a flame-ionization detector (GLC-FID) and a BPX70
capillary column (50m0.32mm0.25mm; SGE Europe Ltd, Courtaboeuf, France). Analysis
conditions were as follows: injector (split 10:1; injection volume 1mL) and detector temperatures
were 250 8C and 2708C, respectively; carrier gas was Hydrogen (11psi) and the oven temperature
programme started at 60 8C (hold 2min), raised 10 8C/min to 1358C (hold 2min), then 10 8C/min to
1658C (hold 2min) and finally 108C/min to 2308C (hold 7min).
For the analysis of EFAME and NEFAME in plasma and PMO samples (Test 4), due to the presence of
trans fatty acids and conjugated linolenic acid isomers (CLnA), a 120m0.25mm0.25mm BPX70
column (SGE Europe Ltd, Courtaboeuf, France) was installed in the HP6890 gas chromatograph.
Conditions were, split 10:1, injection volume 1mL, injector temperature 2508C, detector (FID)
temperature 290 8C, carrier pressure (Hydrogen) 30psi while the oven programme was as follows:
70 8C hold 1min, 78C/min to 170 8C (hold 41min), 58C/min to 2308 (hold 17min).
Supelco 37, tung oil and CRM-164 were used for identification of fatty acids. GLC-Nestlé36 was
assayed for calculation of response factors. All the preparations and analysis described in this research
work were performed in triplicate.
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In a first instance, data were examined for the presence of outliers and an exploratory analysis of
data was performed to test normal distribution and homogeneity of variance (Levene’s test). Then, in
Tests 1, 2 and 4 comparison of data was accomplished through t-Student procedure. Comparison of
data in Test 3 was performed using the ANOVA procedure with Bonferroni’s or Tamhane’s as post hoc
according to homogeneity of variance. Analyses were conducted with the aid of the SPSS Statistics
software v22.0 for Mac (IBM, Armonk, NY, USA). Level of significance was fixed at p<0.05.
Assays to improve the method
The mains drawback in the GC analysis of EFA and NEFA in biological and food samples is the need
to include isolation and fractionation steps while its preparation or the utilization of hazardous
reagents as diazomethane during the esterification of NEFA [2]. However, Yi et al. [1] reported in
2007 a direct derivatization/fractionation procedure avoiding such cumbersome and time-consuming
steps on the basis that acylglycerols can be transesterified using mild conditions together with an
alkali-catalyst while NEFA can be transformed into FAME using an acid catalyst [3]. Due to these a
priori advantages over other techniques, the method was assayed in order to utilize it in further
studies.
Test 1: Assaying the transesterification and esterification ratios
During the adaptation of this method in our lab, a first experience was conducted using 100mL of
tritridecanoine (TG-C13; 1.3mg/mL) and heptadecanoic acid (FFA-C17; 1.4mg/mL) placed into the
reaction tube and evaporated to dryness with a stream of nitrogen. A volume of 1mL of the EFAME and
NEFAME extracts was used for analysis and spiked with 100mL of methyl tricosanoate (FAME-C23;
1.3mg/mL). The original method used KOH in MeOH as base-catalyst but according to previous studies
focused in the development of single-step derivatization methods [4], the utilization of MetNa at the
same concentration than KOH in the original method as an alternative reagent and DMF as protectant
added during the esterification reaction were assayed.
The obtained results (Fig. 1) showed that transesterification of TG-C13 was incomplete: a 44% using
KOH and 61% using MetNa (p<0.05). Furthermore, in the NEFA extract it was detected the presence of
FAME-C13 when using both reagents (27% in samples with KOH and 10% with MetNa; p<0.05). The
high esterification ratio for FFA-C17 implies that although this compound can dissolve in hexane, it
[(Fig._1)TD$FIG]
Fig. 1. Transesterification (TG-C13) and esterification performance (FFA-C17) as well as cross-contamination of the NEFAME
extract (FAME-C13).
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high lost of FFA-C17.
Interestingly, the EFAME were collected with 4mL of hexane and the recovered volume was
recorded using graduated glass tubes. Thus, it was found that this extract has a final volume of 3.5mL.
This may point outs that 500mL of hexane remained dissolved in the MeOH being the source of
contamination in the NEFAME extract. Although specific reactions were used to derivatize EFA and
NEFA, the final product is the same (FAME); therefore any contamination of the NEFAME extract with
EFAME is not acceptable as the obtained composition would not be reliable. In the original method,
samples were added with a standard mix of FFA-C17 and FAME-C17. This place some problems as an
internal standard must have the same chemical characteristics of the compound to be quantified (e.g.
a triacylglycerol for quantitation of acylglycerols, a free fatty acid for NEFA), otherwise, as our data
show, the derivatization performance would not be considered during calculations. Furthermore, if a
FAME is added, it should not be the same final product of any of the other standards as this will also
affect the calculations or will not allow to detect cross-contaminations. At this point, the method
needs some modification to increase the reliability of the data.
Other official methods intended for the analysis of EFA in dairy products proposed reaction times of
5min [5] while some authors reported that times above 3–4min may lead to the hydrolysis of the
FAME, released as free fatty acids [6,7]. These authors also concluded that the addition of an apolar
solvent into the reaction mixture (e.g. hexane) increased the FAME/acylglycerols ratio.
Test 2: Modifications to increase the effectiveness of FAME from acylglycerols
The following experience (Fig. 2) was intended to increase the derivatization performance of the
TG-C13 through decreasing the total reaction time to 3–4min. For such purpose a mixture of TG-C13
(1.3mg/mL), heptadecanoic acid (FFA-C17; 1.4mg/mL) and FAME-C23 (1.3mg/mL) was assayed and
the final EFAME and NEFAME extracts were added with 100mL of FAME-C11 (1.3mg/mL). For a better
control of the transesterification of acylglycerols, the reaction was stopped by adding 230mL H2SO4
(3M) in MeOH. The effect of the presence of hexane (2mL vs. 4mL) during the formation of EFAME was
also studied. Furthermore, Castro-Gómez et al. [4] reported that for the derivatization of free fatty[(Fig._2)TD$FIG]
Fig. 2. Effect of the modifications of the original method assayed in Test 2, in the transesterification using KOH as base-catalyst
and esterification performance (A) as well as cross-contamination of the NEFAME extract (B).
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also tested using a dry-block giving a minimum temperature of 40 8C.
As it was not observed differences among the utilization of KOH or MetNa only data from KOH
experiments are reported. According to the obtained results (Fig. 2A), the proposed modifications
increased the transesterification performance (TG-C13) while it was not found significant differences
associated to the addition of 2 or 4mL in this parameter. The FAME-C23 was added to the reaction
mixture in order to understand the behaviour of these kinds of compounds during the derivatization of
EFA and the effectiveness of the isolation of the final products. It seems that methyl esters rapidly
moved into the hexane layer. Araujo et al. [8], working in a method for the analysis of fatty acids from
various matrices, proposed that the conversion of TG into FAME occurred in an effective methylation
area (EMA), placed in the limit between the hexane and MeOH layers. However, on the basis of the
results of this work, the EMA seems to be an interface layer where part of the hexane (dissolving some
of the acylglycerols) and MeOH (dissolving the alkali and NEFA) mix (Fig. 3). It is also possible that
compounds from the upper and lower layers can move to the interface. Thus, if some TG have to
migrate from the hexane to the EMA, transform into FAME and them being transferred to the hexane
layer again, it may explain that the concentrations of FAME-C13 in the NEFAME extracts were higher
than those of the FAME-C23.
On the other hand, the assayed modifications lowered the amounts of FAME-C13 found in the
NEFAME extract when compared with the results of the Test 1. Moreover, the higher the volume of
hexane in the reaction mixture during step 1 the lower the contamination in terms of FAME-C13 and
FAME-C23 in that extract (p<0.05). The esterification performance for FFA-C17 was similar to those in
the Test 1 in accordance with Castro-Gómez et al. [4].
In the following assays, transesterification was carried out in the presence of 4mL and hexane
while the conditions for the esterification were 30min at 40 8C.[(Fig._3)TD$FIG]
Fig. 3. Distribution of EFA, NEFA and FAME during the transesterification reaction.
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The information from Tests 1 and 2 showed that the separation of the upper from the lower layer
was not complete and that improvement of the derivatization ratio did not avoid the presence of
FAME-C13 in the NEFAME extract. Therefore, the remaining volume of hexane in the methanol layer
is the source of such contamination. In order to solve this drawback, the method was assayed
(without sample) including a new step after collection of the 4 mL of hexane (EFAME extract):
addition of 250, 500 or 1000mL of water to increase the polarity of the methanol (Fig. 4). Thus, only by[(Fig._4)TD$FIG]
Fig. 4. Effect of addition of water after collection of the EFAME extract in the total volume recovered.
[(Fig._5)TD$FIG]
Fig. 5. Derivatization performance (TG-C13 and FFA-C17) and contamination of the NEFAME extract (FAME-C13) resulting from
Test 3.
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water was assayed in further experiments. It was observed that this recovered volume of 500mL of
hexane had some traces of MeOH; thus it was discarded in further experiments.
Then the method was assayed with the same standard mix used in Test 2 (Fig. 5). Some authors
reported the utilization of a mixture of hexane:MTBE (3:1) for the analysis of fatty acids in milkfat
[7]. As polarity seems to play an important role in the derivatization performance and hexaneTable 1
EFA and NEFA composition in the assayed animal-based control serum.
Fatty acid EFA Fatty acid NEFA
KOH (n=3) MetNa (n=3) KOH (n=3) MetNa (n=3)
Mean SD Mean SD Mean SD Mean SD
C14 4.00 0.10 3.92 0.23 C15ai DMA 0.73 0.07 0.76 0.11
C15ai 0.38 0.04 0.41 0.07 C15i DMA 0.41 0.08 0.41 0.11
C14:1 c9 0.50 <0.01 0.46 0.02 C14 3.86 0.42 3.91 0.58
C15i 0.74 0.05 0.65 0.09 C14 DMA 0.80 0.08 0.81 0.14
C15 1.55 0.14 1.44 0.13 C15 0.35 0.02 0.38 0.08
C16i 0.97 0.10 0.82 0.14 C16 DMA 4.69 0.67 4.80 0.74
C16 93.49 6.31 90.40 6.90 C16i 0.16 0.01 0.14 0.03
C16:1 c7 1.62 0.04 1.54 0.06 C15:1 0.48 0.05 0.50 0.08
C16:1 c9 5.31 0.09 5.17 0.30 C16 10.46 1.12 9.77 1.40
C17i 0.93 0.10 0.91 0.12 C16:1 c7 0.19 0.02 0.18 0.03
C17ai 1.55 0.16 1.53 0.14 C16:1 c9 0.81 0.07 0.73 0.08
C16 Phy 29.52 3.29 28.34 3.37 C17i 0.25 0.02 0.22 0.03
C16:2 c9t12 2.00 0.22 1.91 0.24 C17ai 0.34 0.01 0.33 0.04
C17 3.06 0.32 2.95 0.32 C16 Phy 0.58 0.06 0.51 0.04
C17:1 c9 0.45 0.01 0.39 0.10 C16:2 c9t12 0.12 0.02 0.10 0.03
C17:1 c10 0.59 0.05 0.52 0.08 C17 0.39 0.03 0.38 0.04
C18i 0.99 0.07 0.88 0.11 C18 DMA 0.89 0.15 0.86 0.10
C18ai 0.58 0.01 0.37 0.11 C17:1 c9 0.05 0.04 0.03 0.05
C18 89.86 9.12 86.78 8.94 C17:1 c10 0.11 0.04 0.12 0.03
C18:1 t9 0.59 0.18 0.40 0.01 C18i 0.22 0.05 0.21 0.07
C18:1 t10 0.29 0.03 0.23 0.01 C18ai 0.29 0.11 0.29 0.11
C18:1 t11 2.75 0.19 2.61 0.26 C18 9.84 0.86 9.11 0.89
C18:1 t12 2.13 0.12 1.97 0.21 C18:1 t9 0.41 0.10 0.42 0.08
C18:1 c9 117.31 5.10 113.07 6.69 C18:1 t10 0.09 0.02 0.09 0.02
C18:1 t15 0.49 0.03 0.47 0.05 C18:1 t11 0.52 0.09 0.51 0.09
C18:1 c11 4.74 0.18 4.62 0.30 C18:1 t12 0.25 0.04 0.25 0.05
C18:1 c12 1.13 0.08 1.09 0.13 C18:1 c9 10.92 1.86 10.13 1.69
C18:1 c13 0.64 0.02 0.61 0.10 C18:1 t15 0.14 0.03 0.16 0.02
C18:2 t9t12 0.72 0.11 0.61 0.04 C18:1 c11 0.59 0.09 0.56 0.06
C18:1 t16 0.41 0.12 0.36 0.13 C18:1 c12 0.13 0.01 0.15 0.02
C18:2 c9c12 88.74 7.95 85.96 7.98 C18:1 c13 0.12 0.02 0.17 0.02
C18:3 n6 1.25 0.11 1.19 0.15 C18:1 t16 0.11 0.01 0.16 0.02
C18:3 n3 11.92 1.30 11.70 1.38 C18:2 t9t12 0.29 0.06 0.21 0.02
C20 0.21 0.06 0.15 0.01 C18:2 c9c12 5.93 0.81 5.27 0.44
C18:2 c9t11 1.05 0.05 1.09 0.13 C18:3 n6 0.12 0.01 0.11 0.01
C20:1 c9 0.94 0.12 0.91 0.04 C18:3 n3 1.43 0.17 1.36 0.13
C21 1.29 0.33 1.26 0.09 C18:2 c9t11 0.32 0.14 0.32 0.10
C20:2 c11c14 0.94 0.17 0.96 0.10 C20:1 c9 0.50 0.11 0.41 0.06
C20:3 n3 10.74 1.30 10.45 1.27 C20:3 n3 0.56 0.09 0.46 0.05
C20:4 n6 13.64 1.62 13.33 1.55 C20:4 n6 0.97 0.17 0.81 0.08
C22:1 c7 5.63 0.90 5.79 0.93 C22:1 c7 0.50 0.08 0.35 0.08
C20:5 n3 5.06 0.61 4.87 0.57 C20:5 n3 0.59 0.06 0.59 0.09
C24 0.31 0.04 0.30 0.03 C24 0.58 0.23 0.50 0.07
C22:5 n6 1.40 0.13 1.36 0.15 C22:5 n6 0.20 0.03 0.21 0.01
C22:5 n3 5.76 0.74 5.51 0.66 C22:5 n3 0.46 0.09 0.37 0.04
C22:6 n3 4.29 0.48 4.16 0.50 C22:6 n3 0.31 0.03 0.26 0.05
mg/dL 522.48 41.63 504.40 45.41 mg/dL 62.05 8.04 58.37 7.94
ai: ante iso; i: iso; c/t: cis/trans double bond; Phy: phytamic acid; n6: v6 fatty acid; n3: v3 fatty acid; DMA: dimethylacetal.
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(KOH-B; MetNa-B).
As in previous assays accomplished in this research work, it was not found differences from the
utilization of KOH or MetNa in the production of EFAME. Although the hexane:MTBE 3:1 yielded
transesterification ratios higher (p<0.05) than when using only hexane, it resulted into a negativeTable 2
EFA and NEFA composition of the assayed pomegranate oil.
Fatty acid EFA
KOH (n=3) MetNa (n=3)
Mean SD Mean SD
C16 30.91 1.39 29.52 <0.01
C16:1 c9 0.60 0.03 0.61 0.04
C17 0.72 0.02 0.67 0.03
C18 25.28 0.82 24.66 0.20
C18:1 t9 0.90 0.26 1.12 0.04
C18:1 t10 1.97 0.15 2.00 0.11
C18:1 t11 2.22 0.19 2.30 0.10
C18:1 t12 2.00 0.12 2.02 0.10
C18:1 c9 61.20 2.53 58.61 0.07
C18:1 t15 0.76 0.03 0.73 0.06
C18:1 c11 5.07 0.16 4.90 0.02
C18:1 c12 0.37 0.03 0.36 0.04
C18:1 c13 0.83 0.12 0.97 0.01
C18:2 t9t12 0.63 0.02 0.61 0.01
C18:1 t16 0.65 0.19 0.79 0.05
C18:2 c9t12 4.18 0.18 3.94 0.06
C18:2 c9c12 59.97 2.95 56.99 0.04
C18:3 n6 0.59 0.09 0.55 0.05
C18:3 t 0.00 <0.01 0.00 <0.01
C18:3 n3 0.58 0.09 0.53 0.04
C18:2 c9t11 9.01 0.63 8.25 0.13
C20:1 c9 7.93 1.16 6.85 0.07
C20:1 c11 4.39 0.53 3.70 0.16
C22 2.49 0.33 2.13 0.04
C18:3 c9t11c13 598.48 23.41 569.81 5.25
Other CLNA 178.45 29.28 160.32 11.16
mg/mg 1000.17 62.50 942.94 5.27
Fatty acid NEFA
KOH (n=3) MetNa (n=3)
Mean SD Mean SD
C16 5.42 0.19 5.58 0.04
C16:1 c9 1.13 0.08 1.21 <0.01
C17 0.22 0.01 0.22 0.01
C18 1.61 0.19 1.76 0.05
C18:1 c9 6.58 0.62 7.08 0.13
C18:1 c11 0.46 0.04 0.47 0.03
C18:2 c9t12 0.19 <0.01 0.17 0.01
C18:2 c9c12 7.35 0.69 7.94 0.10
C18:3 n3 0.59 0.05 0.64 <0.01
C18:2 c9t11 0.73 0.04 0.78 0.01
C20:1 c9 0.25 0.03 0.30 0.02
C22 0.03 <0.01 0.03 <0.01
C18:3 c9t11c13 20.94 2.35 22.74 0.56
Other CLNA 12.70 1.92 14.39 0.22
mg/mg 58.20 6.21 63.30 1.12
c/t: cis/trans double bond; n6: v6 fatty acid; n3: v3 fatty acid.
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amount of MTBE (p<0.05). This can be explained as MTBE increased the solubility of NEFA in the
hexane:MTBE mixture.
The addition of water, after isolation of the EFAME, resulted in the absence of contamination when
this extract was composed only by hexane. However, the presence of MTBE resulted in 1% (3:1) and 3%
(1:3) of FAME-C13 in the NEFAME extract (p<0.05).
Test 4. Assaying the final method with plasma and pomegranate oil samples
At this point, the method including all the modifications from Tests 1–3 (i.e. addition of 4 mL of
hexane during transesterification and 3–4 min. of reaction time; addition of 500mL of water for a
full recovery of the EFAME extract; esterification conditions of 30 min at 40 8C) was assayed for the
in situ preparation of EFAME and NEFAME using 500mL of animal plasma and 5 mg of
pomegranate oil (Tables 1 and 2). The procedure was also tested in order to know if the utilization
of KOH or MetNa has any impact in the fatty acid composition. Thus, samples were spiked with
100mL of TG-C13 and 100mL of FFA-C19 (due to the presence of C17 in the pomegranate samples)
both 1.3 mg/mL in hexane. EFAME and NEFAME extracts were added with 100mL FAME-C11
(1.3 mg/mL), evaporated to dryness with a gentle stream of nitrogen and resuspended to 100mL
and 50mL respectively.
The derivatization performance for TG-C13 and FFA-C19 was above the 95% without statistical
differences for the utilization of KOH or MetNa as base-catalyst (data not shown). Furthermore, FAME-
C13 was not detected in the NEFAME extracts in none of the assayed samples.
According to the obtained data, both KOH and MetNa resulted in similar EFA compositions
(p<0.05) as well as did not affected to the NEFA profile.
Summary: Final proposed method
According to the results from Tests 1–4, the recommended modifications assure the reliability of
the EFA and NEFA composition when comparing with the original method and these are consisting in:1. Addition of 4mL of hexane to the transesterification mixture.
2. Derivatization time for acyglycerols of 3–4min, stopping the reaction with 230mL H2SO4 (3M) in
MeOH.
3. Addition of 500mL of water after collection of the EFAME extract.
4. Esterification conditions for NEFAME, 30min at 40 8C.
Thus, summarizing the method:1. Add internal standards into a glass tube with heat resistant cap: 100mL of a TG (1.3mg/mL) and
100mL of a FFA (1.3mg/mL) according to the composition of the sample.2. Place the sample (5–10mg (oil)/250mL (e.g. plasma/milk))+2mL MeOH+4mL hexane.
3. Vortex 30s. Warm mixture at 40 8C in a dry-block.
4. Add 0.5mL MetNa (2.5M): reaction starts with the first drop and must not be longer than 3–4m
(Vortex frequently).
5. Stops reaction with 230mL H2SO4 (3M).
6. Cool into ice; separation of organic layers: 1250g, 5min, 258C.
7. Pipetting of 3–3.5mL hexane to 15mL Falcon; evaporate, resuspend to a proper concentration and
put in a vial containing 100mL of a FAME standard (1.3mg/mL).
8. Eliminate the remaining hexane. Add 250–500mL of water and eliminate. It is recommended not
to pool as it may content traces of MeOH.
9. Wash the reaction medium with 2mL of hexane. Vortex 30sg; 1250g, 5min, 258C and discard.10. Add 1.25mL DMF+1.25mL 3M H2SO4; 40–50 8C, 30min (Vortex frequently).
11. Cool in ice; addition of 2–4mL hexane to isolate NEFAME; Vortex 30s; 1250g, 5min, 258C.
L.L. Pimentel et al. / MethodsX 2 (2015) 475–48448412. Recover a proper amount of the upper layer, evaporate to dryness with a gentle stream of nitrogen
if need, redissolve using an appropriate volume and place into a vial containing 100mL of a
selected FAME standard (1.3mg/mL).Acknowledgements
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